Back to Search
Start Over
Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation
- Source :
- ATHEROSCLEROSIS, 266, 196-204. ELSEVIER IRELAND LTD, Atherosclerosis, 266, 196-204. Elsevier Ireland Ltd, Atherosclerosis
- Publication Year :
- 2017
-
Abstract
- Background and aims Increased proinsulin relative to insulin levels have been associated with subclinical atherosclerosis (measured by carotid intima-media thickness (cIMT)) and are predictive of future cardiovascular disease (CVD), independently of established risk factors. The mechanisms linking proinsulin to atherosclerosis and CVD are unclear. A genome-wide meta-analysis has identified nine loci associated with circulating proinsulin levels. Using proinsulin-associated SNPs, we set out to use a Mendelian randomisation approach to test the hypothesis that proinsulin plays a causal role in subclinical vascular remodelling. Methods We studied the high CVD-risk IMPROVE cohort (n = 3345), which has detailed biochemical phenotyping and repeated, state-of-the-art, high-resolution carotid ultrasound examinations. Genotyping was performed using Illumina Cardio-Metabo and Immuno arrays, which include reported proinsulin-associated loci. Participants with type 2 diabetes (n = 904) were omitted from the analysis. Linear regression was used to identify proinsulin-associated genetic variants. Results We identified a proinsulin locus on chromosome 15 (rs8029765) and replicated it in data from 20,003 additional individuals. An 11-SNP score, including the previously identified and the chromosome 15 proinsulin-associated loci, was significantly and negatively associated with baseline IMTmean and IMTmax (the primary cIMT phenotypes) but not with progression measures. However, MR-Eggers refuted any significant effect of the proinsulin-associated 11-SNP score, and a non-pleiotropic SNP score of three variants (including rs8029765) demonstrated no effect on baseline or progression cIMT measures. Conclusions We identified a novel proinsulin-associated locus and demonstrated that whilst proinsulin levels are associated with cIMT measures, proinsulin per se is unlikely to have a causative effect on cIMT.<br />Highlights • Identification of a novel proinsulin-associated locus on chromosome 15. • Lead chromosome 15 SNP rs8029765 influences expression of UNC45A in liver. • Proinsulin effects on carotid intima-media thickness are segment-specific. • Proinsulin-increasing SNP scores had limited effects on carotid intima-media thickness. • Proinsulin is unlikely to have causal effects on intima-media thickness.
- Subjects :
- Carotid Artery Diseases
Male
EXPRESSION
endocrine system
Genetic variants
endocrine system diseases
Quantitative Trait Loci
PATHOPHYSIOLOGY
DEPENDENT DIABETES-MELLITUS
Vascular Remodeling
Carotid Intima-Media Thickness
Polymorphism, Single Nucleotide
INTIMA-MEDIA THICKNESS
Article
Gene Frequency
Risk Factors
Intima-media-thickness
Humans
Genetic Predisposition to Disease
Cardiac and Cardiovascular Systems
CORONARY-HEART-DISEASE
COHORT
cardiovascular diseases
Mendelian randomisation
EUROPEAN POPULATION
COMMON
Genetic Association Studies
Chromosomes, Human, Pair 15
Kardiologi
MEN
Single nucleotide polymorphisms
Mendelian Randomization Analysis
Atherosclerosis
INSULIN
Europe
Phenotype
Asymptomatic Diseases
Linear Models
cardiovascular system
Female
hormones, hormone substitutes, and hormone antagonists
Proinsulin
Subjects
Details
- Language :
- English
- ISSN :
- 00219150
- Database :
- OpenAIRE
- Journal :
- ATHEROSCLEROSIS, 266, 196-204. ELSEVIER IRELAND LTD, Atherosclerosis, 266, 196-204. Elsevier Ireland Ltd, Atherosclerosis
- Accession number :
- edsair.pmid.dedup....375682cfe884f4538de6e5f56cc6efbf